Global Dermatology Drugs Market: Industry Analysis and Forecast (2020-2026) by Disease, Route Of Administration, Distribution Channel and Region

Global Dermatology Drugs Market size was valued at US$ XX Mn in 2019 and the total revenue is expected to grow at XX% through 2020 to 2026, reaching nearly US$ XX Mn. The global Dermatology Drugs market report is a comprehensive analysis of the industry, market, and key players. The report has covered the market by demand and supply-side by segments. The global Dermatology Drugs market report also provides trends by market segments, technology, and investment with a competitive landscape. Global Dermatology Drugs Market To know about the Research Methodology :- Request Free Sample Report

Global Dermatology Drugs Market Overview

The global dermatology drug market was at US$ 36.84 Bn in 2019 and is expected to reach US$ XX BY 2026. Dermatology is defined as a therapy that deals with diseases such as acne vulgaris, fungus, psoriasis, eczema related to the skin. Dermatology drugs are used for the treatment of this disease. Currently, there are various types of drugs available in the market for treatment. The FDA Center for Drug Evaluation and Research is responsible for the study and evaluation of drugs before they are approved for sale and commercial use. A team of CDRE, consisting of a Physician, Pharmacist, and a Statistician who then determines if the drugs are effective and risk-free or not. A patient may choose to go for either allopathic or homoeopathic treatment depending on his choice, according to reports dermatologists provide more than 7 million medicinal prescriptions than any other specialist. Success in dermatology is measured by the efficiency of the medicine in treating certain skin or other conditions, therefor dermatologist prescribes the most clinically proven medicine for the treatment

Global Dermatology Drugs Market Dynamics

The growing number of patients suffering from acne, fungus, and dermatitis are driving the market growth of dermatology drugs. As per the reports of the American Association of Dermatologists approximately 50 million people in the US alone are affected by acne. There are many reasons which can cause skin and other related problems such as not cleaning body properly, excessive sweating, eating spicy food, and wearing tight clothes. Due to which the market is noting an increase in the number of drug sales for treatments. An increase in awareness and among the population about skin and hair infections is proven to be opportunistic for market growth. As the rise in awareness has propelled the sale of OTC medicines has grown, which helps in treating acne and hair fall commonly. Mostly a section of the young population and teens are affected by skin-related issues such as skin irritation, pimples, and excessive sweating due to hormonal changes. With the rise in demand for dermatological drugs which are used on routine and applied topically as anti-inflammatory agent and cleanser are expected to grow market further. Other factors include an increase in investments in the Research and Development by market key players for the production and clinical trials of new drugs due to the rise in demand for new, effective, and less costly drugs Combined with the increase in skin cancer and disorders are helping in the growth of the drugs market. However several side effects and improper use of dermatological drugs combine with government restrictions and parameters will restraint the market from reaching its potential. Trends in Dermatology Drugs Market An increase in the approval of Drugs by various scientific and government authorities has been the most opportunistic way for the growth of the market, Due to a continuous increase in the demand for low and cost-effective drugs despite the high complexity of clinical trials and cost related to its launch of new drugs to generate more revenue in is the trend. Especially in the USA, the Food and Drug Administration has ramped up the process of approval.

Global Dermatology Drugs Market Segment Analysis

Global Dermatology Drugs Market On the basis of Route of Administration the dermatology market is segmented into Acne Psoriasis, Atopic Dermatitis, Eczema, Rosacea, Itchthyosis, Vitiligo and others of which the segment of psoriasis accounted for the most of the drugs market. Psoriasis is a skin disease that causes red, itchy patches commonly on knees, elbows, trunk, and scalp by multiplying skin cells by 10 times and is a chronic disease that has no permanent cure. It is non- transmittable between people but it can affect members of the same family due to common use of things. Because of this dermatology market has noted growth over the years. The segment of Acne has also witnessed tremendous growth and is expected to hold a major market share in the coming years. As per the reports, it affects 9.4% of the world's population of which adolescents are more prone and is common in North America. It makes skin look bad with red spots on cheeks and forehead, causes pain when touched, takes a long time to heal which can cause emotional breakdown sometimes. Because of this, the sale of dermatologically tested creams, moisturizers, and OTC medicines has increased. Based on the Route of administration the segment of Parenteral has dominated the market. In the words of the US Food and Drug Administration, it is defined as the way of administrating a drug in a patient's body through injection, infusion, and implantation, or some other way. It is used when certain drugs are less effective when given orally or the need for the drug is immediate for patients. The segment of Topical Delivery has also seen an upsurge in the market due to the easy availability of a variety of dermatologically proven drugs in the market. It is used to cure skin diseases or disorders on the surface or local area. Based on the distribution channel the segment of hospital pharmacies has accounted for the majority of the market. Due to the preference of patients visit for treatment in hospitals. Hospital pharmacy makes available certain drugs easily which are not available easily. Whereas the segment of retail pharmacy is also on the growth due to increase in demand for cost-effective OTC drugs in the market and is anticipated to gain more market share in the forecast period.

Global Dermatology Drugs Market Regional Insights:

Global Dermatology Drugs Market Regional Insights North America accounted for the majority of market because of more effects of skin disorders and disease in the region. In 2018 market was at US$ 18.10 bn. According to data of statistica.com in the US people belonging to the age group of 18 to 29 paid the highest percentage of the visit to the dermatologist which stands at 16.9% followed by 50-64 years with 15.73% and 30-49 with 12.91%. Moreover, the presence of major market key players combined with the launch of new drugs is driving the market growth. USA, Canada, Mexico are the major contributors in the regions market growth. The European region stands second in the market due to high investments in research and development by major players for the production of new drugs. An increase in the impact of skin disease among people combined with fewer visits paid by them for the treatment is propelling the market. Skin disorders and diseases are the fourth most common human illness due to which the demand for drugs has grown over time. France, Germany, and Italy are the major contributors to the region's market growth because of more number of young patients. Middle East and Africa region is also showing growth rates due to the shifting of key players in the region and increasing awareness. Asia-Pacific region is expected to register the highest market growth because of growing knowledge of skin infections and the availability of proper skin treatments in the region. Availability adequate health care facilities has boosted the market growth. The most significant factor behind the growth of the market in this region is the conduction of the Asia-Pacific Dermatology conference in different nations annually. Where nations of Asia-pacific come together and discuss points on progression, collaboration, ideas for improved patient treatment, and development of drugs in the region. India, China, and Japan are the major holders of market share in the region. The objective of the report is to present a comprehensive analysis of the Global Dermatology Drugs Market to the stakeholders in the industry. The past and current status of the industry with the forecasted market size and trends are presented in the report with the analysis of complicated data in simple language. The report covers all the aspects of the industry with a dedicated study of key players that include market leaders, followers, and new entrants. PORTER, SVOR, PESTEL analysis with the potential impact of micro-economic factors of the market have been presented in the report. External as well as internal factors that are supposed to affect the business positively or negatively have been analyzed, which will give a clear futuristic view of the industry to the decision-makers. The report also helps in understanding the Global Dermatology Drugs Market dynamics, structure by analyzing the market segments and project the Global Dermatology Drugs Market size. Clear representation of competitive analysis of key players by product, price, financial position, product portfolio, growth strategies, and regional presence in the Global Dermatology Drugs Market make the report investor’s guide.

Global Dermatology Drugs Market Scope: Inquire before buying

Global Dermatology Drugs Market

Global Dermatology Drugs Market, by Region

• North America • Europe • Asia Pacific • Middle East and Africa • South America

Global Dermatology Drugs Market Key Players

• Novartis AG • Bausch Health Companies Inc., • Bristol-Myers Squibb Company, • Pfizer Inc. • Merck & Co. Inc. • Johnson & Johnson • AbbVie Inc. • Amgen Inc. • Galderma S.A. • Eli Lilly and Company • Mylan N.V. • GlaxoSmithKline plc • Sanofi, • LEO Pharma A/S.
1. Preface 1.1. Market Definition and Key Research Objectives 1.2. Research Highlights 2. Assumptions and Research Methodology 2.1. Report Assumptions 2.2. Abbreviations 2.3. Research Methodology 2.3.1. Secondary Research 2.3.1.1. Secondary data 2.3.1.2. Secondary Sources 2.3.2. Primary Research 2.3.2.1. Data from Primary Sources 2.3.2.2. Breakdown of Primary Sources 3. Executive Summary: Global Dermatology Drugs Market Size, by Market Value (US$ Mn) 3.1. Global Market Segmentation 3.2. Global Market Segmentation Share Analysis, 2019 3.2.1. Global 3.2.2. By Region (North America, Europe, Asia Pacific, South America, Middle East Africa) 3.3. Geographical Snapshot of the Dermatology Drugs Products Market 3.4. Geographical Snapshot of the Dermatology Drugs Products Market, By Manufacturer share 4. Global Dermatology Drugs Market Overview, 2019-2026 4.1. Market Dynamics 4.1.1. Drivers 4.1.1.1. Global 4.1.1.2. By Region (North America, Europe, Asia Pacific, South America, Middle East Africa) 4.1.2. Restraints 4.1.2.1. Global 4.1.2.2. By Region (North America, Europe, Asia Pacific, South America, Middle East Africa) 4.1.3. Opportunities 4.1.3.1. Global 4.1.3.2. By Region (North America, Europe, Asia Pacific, South America, Middle East Africa) 4.1.4. Challenges 4.1.4.1. Global 4.1.4.2. By Region (North America, Europe, Asia Pacific, South America, Middle East Africa) 4.1.5. Industry Trends and Emerging Technologies 4.1.6. Porters Five Forces Analysis 4.1.6.1. Threat of New Entrants 4.1.6.2. Bargaining Power of Buyers/Consumers 4.1.6.3. Bargaining Power of Suppliers 4.1.6.4. Threat of Substitute Products 4.1.6.5. Intensity of Competitive Rivalry 4.1.7. Value Chain Analysis 4.1.8. Technological Roadmap 4.1.9. Regulatory landscape 4.1.10. Impact of the Covid-19 Pandemic on the Global Dermatology Drugs Market 5. Supply Side and Demand Side Indicators 6. Global Dermatology Drugs Market Analysis and Forecast, 2019-2026 6.1 Dermatology Drugs Market Size & Y-o-Y Growth Analysis 7. Global Dermatology Drugs Market Analysis and Forecasts, 2019-2026 7.1. Market Size (Value) Estimates & Forecast By Disease, 2019-2026 7.1.1. Psoriasis 7.1.2. Acne Vulgaris 7.1.3. Atopic Dermatitis 7.1.4. Eczema 7.1.5. Rosacea. 7.1.6. Itchthyosis. 7.1.7. Vitiligo 7.1.8. Others 7.2. Market Size (Value) Estimates & Forecast By Route Of Administration, 2019-2026 7.2.1. Oral 7.2.2. Parenteral 7.2.3. Topical 7.3. Market Size (Value) Estimates & Forecast By Distribution Channel, 2019-2026 7.3.1. Hospital Pharmacy 7.3.2. Retail Pharmacy 7.3.3. Online Pharmacy 7.4. Market Size (Value) Estimates & Forecast by Region, 2019-2026 7.4.1. North America 7.4.2. South America 7.4.3. Europe 7.4.4. Asia Pacific 7.4.5. Middle East and Africa 8. North America Dermatology Drugs Market Analysis and Forecasts, 2019-2026 8.1. Market Size (Value) Estimates & Forecast By Disease, 2019-2020 8.1.1. Psoriasis 8.1.2. Acne Vulgaris 8.1.3. Autopic Dermatits 8.1.4. Eczema 8.1.5. Rosacea. 8.1.6. Itchthyosis. 8.1.7. Vitiligo 8.1.8. Others 8.2. Market Size (Value) Estimates & Forecast By Route Of Administration, 2019-2026 8.2.1. Oral 8.2.2. Parenteral 8.2.3. Topical 8.3. Market Size (Value) Estimates & Forecast By Distribution Channel, 2019-2026 8.3.1. Hospital Pharmacy 8.3.2. Retail Pharmacy 8.3.3. Online Pharmacy 9. North America Dermatology Drugs Market Analysis and Forecasts, By Country 9.1. Market Size (Value) Estimates & Forecast By Country, 2019-2026 9.1.1. US 9.1.2. Canada 9.1.3. Mexico 10. U.S. Dermatology Drugs Market Analysis and Forecasts, 2019-2026 10.1. Market Size (Value) Estimates & Forecast By Disease, 2019-2026 10.2. Market Size (Value) Estimates & Forecast By Route Of Administration, 2019-2026 10.3. Market Size (Value) Estimates & Forecast By Distribution Channel, 2019-2026 11. Canada Dermatology Drugs Market Analysis and Forecasts, 2019-2026 11.1. Market Size (Value) Estimates & Forecast By Disease, 2019-2026 11.2. Market Size (Value) Estimates & Forecast By Route Of Administration, 2019-2026 11.3. Market Size (Value) Estimates & Forecast By Distribution Channel, 2019-2026 12. Mexico Dermatology Drugs Market Analysis and Forecasts, 2019-2026 12.1. Market Size (Value) Estimates & Forecast By Disease, 2019-2026 12.2. Market Size (Value) Estimates & Forecast By Route Of Administration, 2019-2026 12.3. Market Size (Value) Estimates & Forecast By Distribution Channel, 2019-2026 13. Europe Dermatology Drugs Market Analysis and Forecasts, 2019-2026 13.1. Market Size (Value) Estimates & Forecast By Disease, 2019-2026 13.2. Market Size (Value) Estimates & Forecast By Route Of Administration, 2019-2026 13.3. Market Size (Value) Estimates & Forecast By Distribution Channel, 2019-2026 14. Europe Dermatology Drugs Market Analysis and Forecasts, By Country 14.1. Market Size (Value) Estimates & Forecast By Country, 2019-2026 14.1.1. U.K 14.1.2. France 14.1.3. Germany 14.1.4. Italy 14.1.5. Spain 14.1.6. Sweden 14.1.7. CIS Countries 14.1.8. Rest of Europe 15. U.K. Dermatology Drugs Market Analysis and Forecasts, 2019-2026 15.1. Market Size (Value) Estimates & Forecast By Disease, 2019-2026 15.2. Market Size (Value) Estimates & Forecast By Route Of Administration, 2019-2026 15.3. Market Size (Value) Estimates & Forecast By Distribution Channel, 2019-2026 16. France Dermatology Drugs Market Analysis and Forecasts, 2019-2026 16.1. Market Size (Value) Estimates & Forecast By Disease, 2019-2026 16.2. Market Size (Value) Estimates & Forecast By Route Of Administration, 2019-2026 16.3. Market Size (Value) Estimates & Forecast By Distribution Channel, 2019-2026 17. Germany Dermatology Drugs Market Analysis and Forecasts, 2019-2026 17.1. Market Size (Value) Estimates & Forecast By Disease, 2019-2026 17.2. Market Size (Value) Estimates & Forecast By Route Of Administration, 2019-2026 17.3. Market Size (Value) Estimates & Forecast By Distribution Channel, 2019-2026 18. Italy Dermatology Drugs Market Analysis and Forecasts, 2019-2026 18.1. Market Size (Value) Estimates & Forecast By Disease, 2019-2026 18.2. Market Size (Value) Estimates & Forecast By Route Of Administration, 2019-2026 18.3. Market Size (Value) Estimates & Forecast By Distribution Channel, 2019-2026 19. Spain Dermatology Drugs Market Analysis and Forecasts, 2019-2026 19.1. Market Size (Value) Estimates & Forecast By Disease, 2019-2026 19.2. Market Size (Value) Estimates & Forecast By Route Of Administration, 2019-2026 19.3. Market Size (Value) Estimates & Forecast By Distribution Channel, 2019-2026 20. Sweden Dermatology Drugs Market Analysis and Forecasts, 2019-2026 20.1. Market Size (Value) Estimates & Forecast By Disease, 2019-2026 20.2. Market Size (Value) Estimates & Forecast By Route Of Administration, 2019-2026 20.3. Market Size (Value) Estimates & Forecast By Distribution Channel, 2019-2026 21. CIS Countries Dermatology Drugs Market Analysis and Forecasts, 2019-2026 21.1. Market Size (Value) Estimates & Forecast By Disease, 2019-2026 21.2. Market Size (Value) Estimates & Forecast By Route Of Administration, 2019-2026 21.3. Market Size (Value) Estimates & Forecast By Distribution Channel, 2019-2026 22. Rest of Europe Dermatology Drugs Market Analysis and Forecasts, 2019-2026 22.1. Market Size (Value) Estimates & Forecast By Disease, 2019-2026 22.2. Market Size (Value) Estimates & Forecast By Route Of Administration, 2019-2026 22.3. Market Size (Value) Estimates & Forecast By Distribution Channel, 2019-2026 23. Asia Pacific Dermatology Drugs Market Analysis and Forecasts, 2019-2026 23.1. Market Size (Value) Estimates & Forecast By Disease, 2019-2026 23.2. Market Size (Value) Estimates & Forecast By Route Of Administration, 2019-2026 23.3. Market Size (Value) Estimates & Forecast By Distribution Channel, 2019-2026 24. Asia Pacific Dermatology Drugs Market Analysis and Forecasts, by Country 24.1. Market Size (Value) Estimates & Forecast By Country, 2019-2026 24.1.1. China 24.1.2. India 24.1.3. Japan 24.1.4. South Korea 24.1.5. Australia 24.1.6. ASEAN 24.1.7. Rest of Asia Pacific 25. China Dermatology Drugs Market Analysis and Forecasts, 2019-2026 25.1. Market Size (Value) Estimates & Forecast By Disease, 2019-2026 25.2. Market Size (Value) Estimates & Forecast By Route Of Administration, 2019-2026 25.3. Market Size (Value) Estimates & Forecast By Distribution Channel, 2019-2026 26. India Dermatology Drugs Market Analysis and Forecasts, 2019-2026 26.1. Market Size (Value) Estimates & Forecast By Disease, 2019-2026 26.2. Market Size (Value) Estimates & Forecast By Route Of Administration, 2019-2026 26.3. Market Size (Value) Estimates & Forecast By Distribution Channel, 2019-2026 27. Japan Dermatology Drugs Market Analysis and Forecasts, 2019-2026 27.1. Market Size (Value) Estimates & Forecast By Disease, 2019-2026 27.2. Market Size (Value) Estimates & Forecast By Route Of Administration, 2019-2026 27.3. Market Size (Value) Estimates & Forecast By Distribution Channel, 2019-2026 28. South Korea Dermatology Drugs Market Analysis and Forecasts, 2019-2026 28.1. Market Size (Value) Estimates & Forecast By Disease, 2019-2026 28.2. Market Size (Value) Estimates & Forecast By Route Of Administration, 2019-2026 28.3. Market Size (Value) Estimates & Forecast By Distribution Channel, 2019-2026 29. Australia Dermatology Drugs Market Analysis and Forecasts, 2019-2026 29.1. Market Size (Value) Estimates & Forecast By Disease, 2019-2026 29.2. Market Size (Value) Estimates & Forecast By Route Of Administration, 2019-2026 29.3. Market Size (Value) Estimates & Forecast By Distribution Channel, 2019-2026 29.4. Market Size (Value) Estimates & Forecast By Region, 2019-2026 30. ASEAN Dermatology Drugs Market Analysis and Forecasts, 2019-2026 30.1. Market Size (Value) Estimates & Forecast By Disease, 2019-2026 30.2. Market Size (Value) Estimates & Forecast By Route Of Administration, 2019-2026 30.3. Market Size (Value) Estimates & Forecast By Distribution Channel, 2019-2026 31. Rest of Asia Pacific Dermatology Drugs Market Analysis and Forecasts, 2019-2026 31.1. Market Size (Value) Estimates & Forecast By Disease, 2019-2026 31.2. Market Size (Value) Estimates & Forecast By Route Of Administration, 2019-2026 31.3. Market Size (Value) Estimates & Forecast By Distribution Channel, 2019-2026 32. Middle East Africa Dermatology Drugs Market Analysis and Forecasts, 2019-2026 32.1. Market Size (Value) Estimates & Forecast By Disease, 2019-2026 32.2. Market Size (Value) Estimates & Forecast By Route Of Administration, 2019-2026 32.3. Market Size (Value) Estimates & Forecast By Distribution Channel, 2019-2026 33. Middle East Africa Dermatology Drugs Market Analysis and Forecasts, by Country 33.1. Market Size (Value) Estimates & Forecast by Country, 2019-2026 33.1.1. South Africa 33.1.2. GCC Countries 33.1.3. Egypt 33.1.4. Nigeria 33.1.5. Rest of ME&A 34. South Africa Dermatology Drugs Market Analysis and Forecasts, 2019-2026 34.1. Market Size (Value) Estimates & Forecast By Disease, 2019-2026 34.2. Market Size (Value) Estimates & Forecast By Route Of Administration, 2019-2026 34.3. Market Size (Value) Estimates & Forecast By Distribution Channel, 2019-2026 35. GCC Countries Dermatology Drugs Market Analysis and Forecasts, 2019-2026 35.1. Market Size (Value) Estimates & Forecast By Disease, 2019-2026 35.2. Market Size (Value) Estimates & Forecast By Route Of Administration, 2019-2026 35.3. Market Size (Value) Estimates & Forecast By Distribution Channel, 2019-2026 36. Egypt Dermatology Drugs Market Analysis and Forecasts, 2019-2026 36.1. Market Size (Value) Estimates & Forecast By Disease, 2019-2026 36.2. Market Size (Value) Estimates & Forecast By Route Of Administration, 2019-2026 36.3. Market Size (Value) Estimates & Forecast By Distribution Channel, 2019-2026 37. Nigeria Dermatology Drugs Market Analysis and Forecasts, 2019-2026 37.1. Market Size (Value) Estimates & Forecast By Disease, 2019-2026 37.2. Market Size (Value) Estimates & Forecast By Route Of Administration, 2019-2026 37.3. Market Size (Value) Estimates & Forecast By Distribution Channel, 2019-2026 38. Rest of ME&A Dermatology Drugs Market Analysis and Forecasts, 2019-2026 38.1. Market Size (Value) Estimates & Forecast By Disease, 2019-2026 38.2. Market Size (Value) Estimates & Forecast By Route Of Administration, 2019-2026 38.3. Market Size (Value) Estimates & Forecast By Distribution Channel, 2019-2026 39. South America Dermatology Drugs Market Analysis and Forecasts, 2019-2026 39.1. Market Size (Value) Estimates & Forecast By Disease, 2019-2026 39.2. Market Size (Value) Estimates & Forecast By Route Of Administration, 2019-2026 39.3. Market Size (Value) Estimates & Forecast By Distribution Channel, 2019-2026 40. South America Dermatology Drugs Market Analysis and Forecasts, by Country 40.1. Market Size (Value) Estimates & Forecast by Country, 2019-2026 40.1.1. Brazil 40.1.2. Argentina 40.1.3. Rest of South America 41. Brazil Dermatology Drugs Market Analysis and Forecasts, 2019-2026 41.1. Market Size (Value) Estimates & Forecast By Disease, 2019-2026 41.2. Market Size (Value) Estimates & Forecast By Route Of Administration, 2019-2026 41.3. Market Size (Value) Estimates & Forecast By Distribution Channel, 2019-2026 42. Argentina Dermatology Drugs Market Analysis and Forecasts, 2019-2026 42.1. Market Size (Value) Estimates & Forecast By Disease, 2019-2026 42.2. Market Size (Value) Estimates & Forecast By Route Of Administration, 2019-2026 42.3. Market Size (Value) Estimates & Forecast By Distribution Channel, 2019-2026 43. Rest of South America Dermatology Drugs Market Analysis and Forecasts, 2019-2026 43.1. Market Size (Value) Estimates & Forecast By Disease, 2019-2026 43.2. Market Size (Value) Estimates & Forecast By Route Of Administration, 2019-2026 43.3. Market Size (Value) Estimates & Forecast By Distribution Channel, 2019-2026 44. Competitive Landscape 44.1. Geographic Footprint of Major Players in the Global Dermatology Drugs Market 44.2. Competition Matrix 44.2.1. Competitive Benchmarking of Key Players By Price, Presence, Market Share, Distribution Channels and R&D Investment 44.2.2. New Product Launches and Product Enhancements 44.2.3. Market Consolidation 44.2.3.1. M&A by Regions, Investment and Verticals 44.2.3.2. M&A, Forward Integration and Backward Integration 44.2.3.3. Partnership, Joint Ventures and Strategic Alliances/ Sales Agreements 44.3. Company Profile : Key Players 44.3.1. LEO Pharma A/S. 44.3.1.1. Company Overview 44.3.1.2. Financial Overview 44.3.1.3. Geographic Footprint 44.3.1.4. Product Portfolio 44.3.1.5. Business Strategy 44.3.1.6. Recent Developments 45.3.2 Novartis AG 45.3.3 Bausch Health Companies Inc. 45.3.4 Bristol-Myers Squibb Company 45.3.5 Pfizer Inc. 45.3.6 Merck & Co. Inc. 45.3.7 Johnson & Johnson 45.3.8 AbbVie Inc. 45.3.9 Amgen Inc. 45.3.10 Galderma S.A. 45.3.11 Eli Lilly and Company 45.3.12 Mylan N.V. 45.3.13 GlaxoSmithKline plc 45.3.14 Sanofi 46 Primary Key Insights

About This Report

Report ID 107428
Category Food & Beverages
Published Date Jun 2021
Updated Date
Contact Us